Occidental Announces 4th Quarter and Full-Year 2019 Results
HOUSTON, Feb. 27, 2020 (GLOBE NEWSWIRE) — Occidental Petroleum Corporation (NYSE:OXY) today announced its fourth quarter and full year 2019 […]
FTAI Reports Record Fourth Quarter and Full Year 2019 Results, Dividend of $0.33 per Common Share
NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) (the “Company” or “FTAI”) today […]
Par Pacific Holdings Management to Participate in March 2020 Investor Conferences
HOUSTON, Feb. 27, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that members of its […]
DCP Midstream Publishes Inaugural Sustainability Report
DENVER, Feb. 27, 2020 (GLOBE NEWSWIRE) — Today, DCP Midstream, LP (NYSE: DCP) announces the publication of its inaugural Sustainability […]
Black Hills Corp. Closes $100 Million Equity Issuance and Reaffirms Guidance Range
RAPID CITY, S.D., Feb. 27, 2020 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced the closing of its […]
Interpublic Group to Present at the 2020 Morgan Stanley Technology, Media and Telecom Conference
New York, Feb. 27, 2020 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the 2020 Morgan […]
Penn Virginia Reports Fourth Quarter and Full-Year 2019 Results
— Generated Net Cash Provided by Operating Activities of $76 Million and Free Cash Flow of $4 Million for the […]
Equillium Strengthens Leadership Team with Key Appointments
Maple Fung, M.D., joins as vice president clinical developmentMatthew Ritter, Ph.D., joins as vice president corporate developmentLA JOLLA, Calif., Feb. […]
BPGIC and FOIZ Have a Prestigious Signing Ceremony for BPGIC’s New Land Lease at London IP Week
NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) — Brooge Holdings Limited (“Brooge Holdings”) (NASDAQ: BROG) and its wholly-owned subsidiary Brooge […]
Immunomedics Appoints Robert W. Azelby to Board of Directors
MORRIS PLAINS, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]
